Andrew C Lee, MD
Cardiovascular Disease (Cardiology) · Redwood City
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 7
Offices
7 locations · Permanente Medical Group Inc · 10,928 clinicians in this group
Looking this up.
Hospitals listed: Kaiser Foundation Hospital-Santa Clara. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Lee’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A81896 · Current
Licensed to practise in California · since 2003 · expires 2027-02-28 · University of Michigan Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Kaiser Foundation Hospital-Santa ClaraSanta Clara, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Kaiser Permanente, which runs 41 hospitals in 3 statesPatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.38, Oct 2024 – Sep 2025
See every measure and the patient survey for Kaiser Foundation Hospital-Santa Clara
Behind the star rating — Deaths: 0 better, 3 the same, 0 worse of 3 measures. Safety: 2 better, 4 the same, 0 worse of 6 measures. Readmissions: 0 better, 1 the same, 1 worse of 2 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.38 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.01 (0 to 2.09) · 181 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.61 to 1.42) | No different | Jul 2022 – Jun 2024 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 312 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 3,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 910 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 1,036 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.53 (2.03 to 7.03) · 235 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.57 (0 to 3.25) · 83 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.5 (0.82 to 4.18) · 178 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.73 (3.81 to 19.64) · 74 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.31 (1.3 to 9.32) · 94 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.22 to 3.28) · 37 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.34 (0 to 1.34) · 819 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.72 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.049 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.598 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.926 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13 · 589 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.7 · 828 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 107.6 · 27 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 642 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 7.8 · 249 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 181 cases | None | Jul 2023 – Jun 2025 |
What patients said (572 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Coronary angioplasty and stenting | 13 | More than 34% of doctors who do this |
Year by year
| 2019 | 14 | 31 | 69 | 3.38 | $61,578 | $7,873 |
| 2017 | 12 | 19 | 72 | 0.91 | $20,782 | $3,669 |
| 2016 | 15 | 27 | 69 | 2.90 | $22,901 | $4,047 |
| 2015 | 22 | 34 | 70 | 3.57 | $25,261 | $4,659 |
| 2014 | 18 | 27 | 72 | 1.41 | $27,845 | $5,732 |
| 2013 | 806 | 2,780 | 77 | 1.67 | $882,064 | $209,321 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2015: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 12 | $89 | $7 |
2013: 32 services
| Return visit (30+ min) | 318 | $34,602 | $77 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 77 | $34,499 | $448 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 78 | $20,290 | $130 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 95 | $15,941 | $164 |
| Injection, regadenoson, 0.1 mg | 61 | $10,072 | None |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 15 | $7,989 | $444 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 33 | $6,541 | $198 |
| Ultrasound of both sides of head and neck blood flow | 39 | $6,405 | $164 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 14 | $5,994 | $428 |
| Long return visit (40+ min) | 39 | $4,378 | $100 |
| New patient visit (45+ min) | 35 | $4,270 | $122 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 22 | $3,918 | $178 |
| New patient visit (60+ min) | 24 | $3,856 | $161 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 61 | $3,460 | $57 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 204 | $3,410 | $13 |
| Blood test, clotting time | 270 | $3,331 | $5 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $3,250 | $81 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,162 | $158 |
| Ultrasound of leg arteries or artery grafts | 16 | $2,848 | $178 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 55 | $2,821 | $51 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 13 | $2,675 | $206 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 11 | $1,667 | $152 |
| Ultrasound of heart blood flow, valves and chambers | 33 | $1,331 | $40 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 62 | $1,306 | $16 |
| Ultrasound study of arm and leg arteries | 14 | $973 | $70 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 51 | $839 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 33 | $603 | $18 |
| Hospital observation care on day of discharge | 11 | $601 | $55 |
| Review by radiologist of 1 arm or leg vein of 1 arm or leg image | 15 | $423 | $28 |
| Programming of dual lead pacemaker system | 12 | $345 | $29 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 15 | $253 | $17 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 15 | $168 | $11 |
Money from drug and device companies
$53 in 2025
| 2025 | 1 | 1 | None | $53 |
| 2024 | 4 | 5 | None | $365 |
| 2023 | 1 | 2 | None | $254 |
| 2020 | 1 | 1 | None | $26 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abiomed | None | $53 | 1 payment
|
See the published payment
| Abiomed | Meals · 2025-05-22 | None | $53 |
See earlier years (2024, 2023, 2020)
2024: $365
| Histosonics | None | $206 | 1 payment
|
| Boston Scientific | None | $74 | 1 payment
|
| Medtronic | Symplicity G3 | $67 | 2 payments
|
| Abiomed | Impella | $19 | 1 payment
|
2023: $254
| Medtronic | Onyx Frontier | $254 | 2 payments
|
2020: $26
| Regeneron Healthcare Solutions | Eylea | $26 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Abbott Laboratories · Xience 28 USA Study · 2020 | Their institution | $18,050 |
| Abbott Laboratories · Xience 28 USA Study · 2022 | Their institution | $3,550 |
| Abbott Laboratories · Xience Short Dapt 28 US · 2021 | Their institution | $2,125 |
Professional record
- NPI
- 1427067669
- Licence
- CA A81896California A81896: Current · expires 2027-02-28
- Trained
- University of Michigan Medical School, 2000
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Cardiology (207RC0000X); Internal medicine (207R00000X)
- Mailing address
- 168 N. Brent Street, Suite 503, Ventura, CA, 93003
- NPI first listed
- 2006-08-05
- NPI last updated
- 2022-02-11
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.